[Trimethoprim VUFB in the therapy of urinary infections].
Twenty women with asymptomatic significant bacteriuria took Trimethoprim (TMP) VUFB, 2 X 200 mg, for eight days. Twelve had morphological changes of the urinary pathways confirmed by intravenous pyelography. The test for the presence of bacteria with an antibody film in the urinary sediment suggested that the infection was in the upper urinary pathways in eight of the women. Immediately after termination of treatment the urine was negative in 16 women (80%), after another three weeks the negative finding persisted in the urine of nine women (45%). In one patient treatment was discontinued after five days on account of dyspeptic complaints, the remaining patients tolerated the drug well.
Horcicková
M
M
Program výzkumu transplantací orgánů, Institutu klinické a experimentální medicíny, Praha.
Prát
V
V
Hatala
M
M
Liska
M
M
Nezádalová
E
E
Milotová
Z
Z
D000293:Adolescent; D000328:Adult; D000368:Aged; D001437:Bacteriuria; D006801:Humans; D008875:Middle Aged; D014295:Trimethoprim / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000652:urine
D014295:Trimethoprim
Trimethoprim VUFB pri terapii mocových infekcí.